Clinical Trial Update: Genetic Test in Detecting Minimal Residual Disease in Samples From Younger Patients Registered on the COG-AALL08B1 Trial

View source ↗

Summary

This clinical trial update describes a genetic test used to detect minimal residual disease in samples from younger patients enrolled in the COG-AALL08B1 trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Snippet

Sponsor: Children's Oncology Group | Conditions: Leukemia | Status: COMPLETED